A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
Public ClinicalTrials.gov record NCT05910450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-month Phase 3, Multicenter, Prospective, Randomized, Double-Blind, Vehicle-Controlled Study, to Evaluate the Efficacy and Safety of Topically Applied Clascoterone Solution for the Treatment of Androgenetic Alopecia in Males, Followed by a 6-month Single-Blind Treatment With Clascoterone or Vehicle Solution
Study identification
- NCT ID
- NCT05910450
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Cassiopea SpA
- Industry
- Enrollment
- 703 participants
Conditions and interventions
Conditions
Interventions
- Clascoterone 5% solution Drug
- Vehicle solution Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 20, 2023
- Primary completion
- Jan 25, 2026
- Completion
- Jan 25, 2026
- Last update posted
- Jun 7, 2026
2023 – 2026
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Petrus Center for Aesthetic Surgery and Hair Transplantation | North Little Rock | Arkansas | 72116 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Mayo Clinic, Department of Dermatology | Jacksonville | Florida | 32224 | — |
| University of Miami | Miami | Florida | 33125 | — |
| DelRicht Research | Baton Rouge | Louisiana | 70809 | — |
| DelRicht Research | New Orleans | Louisiana | 70115 | — |
| Henry Ford Health | Detroit | Michigan | 48202 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| JDR Dermatology Research | Las Vegas | Nevada | 89148 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| Diane S. Berson MD, PLLC | New York | New York | 10022 | — |
| Derm Research Center of New York, Inc. | Stony Brook | New York | 11790 | — |
| On Site Clinical Solutions | Charlotte | North Carolina | 28277 | — |
| DermResearch | Austin | Texas | 78759 | — |
| DelRicht Research | Frisco | Texas | 75034 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05910450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05910450 live on ClinicalTrials.gov.